These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1285594)

  • 1. [Erythroderma induced by teicoplanin].
    Paul C; Janier M; Carlet J; Tamion F; Carlotti A; Fichelle JM; Daniel F
    Ann Dermatol Venereol; 1992; 119(9):667-9. PubMed ID: 1285594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin-induced neutropenia resolves after substitution with teicoplanin.
    Sanche SE; Dust WN; Shevchuk YM
    Clin Infect Dis; 2000 Sep; 31(3):824-5. PubMed ID: 11017842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis.
    Del Pozo JL; García Cenoz M; Hernáez S; Martínez A; Serrera A; Aguinaga A; Alonso M; Leiva J
    Int J Antimicrob Agents; 2009 Nov; 34(5):482-5. PubMed ID: 19713086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case of congestive heart failure associated with hypereosinophilia developed during antibiotics treatment].
    Sato T; Hagiwara K; Matsuno H; Akiyama O
    Arerugi; 2005 Oct; 54(10):1208-12. PubMed ID: 16407668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycopeptides (vancomycin, teicoplanin)--their place in the antibacterial therapy of patients in a high-risk group].
    Beloborodova NV
    Anesteziol Reanimatol; 1998; (4):23-7. PubMed ID: 9770813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: a case report and literature review.
    Hsiao SH; Chen HH; Chou CH; Lin WL; Liu Yeh PY; Wu TJ
    J Clin Pharm Ther; 2010 Dec; 35(6):729-32. PubMed ID: 21054466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red-man syndrome after vancomycin: potential cross-reactivity with teicoplanin.
    Khurana C; de Belder MA
    Postgrad Med J; 1999 Jan; 75(879):41-3. PubMed ID: 10396588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adequate intrathecal diffusion of teicoplanin after failure of vancomycin, administered in continuous infusion in three cases of shunt associated meningitis].
    Jourdan C; Convert J; Peloux A; Boussaid O; Grando J; Tigaud S
    Pathol Biol (Paris); 1996 May; 44(5):389-92. PubMed ID: 8758482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin.
    Hsiao SH; Chang CM; Tsai JC; Lin CY; Liao LH; Lin WL; Wu TJ
    Ann Pharmacother; 2007 May; 41(5):891-4. PubMed ID: 17426073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of vancomycin and teicoplanin against staphylococci in intensive care units.
    Kucukates E
    Natl Med J India; 2004; 17(2):117. PubMed ID: 15141614
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with teicoplanin in the treatment of neonatal staphylococcal sepsis.
    Yalaz M; Cetin H; Akisu M; Yeniay B; Tunger A; Kultursay N
    J Int Med Res; 2004; 32(5):540-8. PubMed ID: 15458287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
    Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
    Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
    Hahn-Ast C; Glasmacher A; Arns A; Mühling A; Orlopp K; Marklein G; Von Lilienfeld-Toal M
    Infection; 2008 Feb; 36(1):54-8. PubMed ID: 18193385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe staphylococcal knee arthritis responding favourably to linezolid, after glycopeptide-rifampicin failure: a case report and literature review.
    Manfredi R; Sabbatani S; Chiodo F
    Scand J Infect Dis; 2005; 37(6-7):513-7. PubMed ID: 16012016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a glycopeptide antibiotic, teicoplanin, in the treatment of septicaemia caused by gram-positive bacteria.
    Webster A; Wilson AP; Treasure T; Grüneberg RN
    Int J Clin Pharmacol Res; 1988; 8(2):95-8. PubMed ID: 2967800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of teicoplanin in the ambulatory treatment of infections in children due to gram-positive microorganisms].
    Debbag R; Paganini H; Gómez S; Casimir L; Stamboulian D
    Medicina (B Aires); 2002; 62 Suppl 2():48-51. PubMed ID: 12481489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical deterioration among patients with fever and erythroderma.
    Byer RL; Bachur RG
    Pediatrics; 2006 Dec; 118(6):2450-60. PubMed ID: 17142531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.